The DEFINE trial: BG-12 reduces relapse rate in multiple sclerosis [Classics Series]
Image: PD 1. BG-12 (dimethyl fumarate) significantly reduces relapse rates, disability progression, and image detectable lesion load over a two-year ...
Image: PD 1. BG-12 (dimethyl fumarate) significantly reduces relapse rates, disability progression, and image detectable lesion load over a two-year ...